Gene Therapy Development for Glaucoma
Posted 2024-04-11 07:56:51
0
1K
Glaucoma is a complex disease, and currently the only way to maintain patient health is by lowering intraocular pressure. Gene therapy to treat the disease is rapidly evolving. This is a much needed area of glaucoma treatment that can be applied to a variety of glaucoma types.
A major risk factor for glaucoma is high IOP and causes blindness primarily due to RGC damage and death. Therefore, Ace Ophthalmology provides gene therapy development services for glaucoma, targeting candidate genes related to IOP and RGC, as well as many other related genes and pathways.
Learn more:glaucoma gene delivery system development service
Cerca
Werbung
Categorie
- Cars & Motorsport
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Giochi
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Altre informazioni
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- IT, Cloud, Software and Technology
Leggi tutto
Shelf Stable Probiotics Market Surpassing prior functional ingredient benchmarks, on track to achieve a global forecast value of USD 9.6 billion by 2036
The global Shelf Stable Probiotics Market is poised for substantial growth through...
North America Stretch and Shrink Film Market Trends and Future Outlook by 2034
North America is a significant market for stretch and shrink films due to the strong presence of...
Building Strong Thinking Skills Through Intellectual Development
Success in academics, careers, and personal life often depends on the ability to think clearly...
The reality behind scale issues in programmatic web platforms
I was talking to a friend who runs a massive content platform with thousands of landing pages...